WIB-Chicago Presents “Clear as Mud?: A Discussion of the Legal, Regulatory, and Business Concerns for Biosimilars in 2018”
Last year was a big one in the world of biosimilars: from doubling the number of approved biosimilar products to obtaining clarity on the legal landscape. Our distinguished panel will discuss the myriad of legal, regulatory, scientific, pricing, and access issues that biosimilar applicants will be facing this year--issues which will determine whether the public will see another banner year for the availability of life- and cost-saving drug therapies.
Moderated by Helen Ji, Associate, Schiff Hardin, our panel includes the following individuals:
- Rekha Hanu, Executive Director, Chief IP Counsel, Akorn Pharmaceuticals
- Christine Simmon, Senior Vice President, Policy & Strategic Alliances, Association for Medicines
* - Walk-ins will be accepted at the door until event capacity is reached.
5:30 p.m. – 6:30 p.m. Registration, Networking, Appetizers, and Opening Remarks
6:30 p.m. – 8:00 p.m. Panel Discussion
8:00 p.m. – 8:30 p.m. Audience Q&A, Dessert Reception
Special Pricing for Guests
When registering, members can register guests at member price